tiprankstipranks
Trending News
More News >
Iovance Biotherapeutics (IOVA)
:IOVA
US Market

Iovance Biotherapeutics (IOVA) Income Statement

Compare
3,900 Followers

Iovance Biotherapeutics Income Statement

Last quarter (Q3 2025), Iovance Biotherapeutics's total revenue was $67.45M, an increase of 15.20% from the same quarter last year. In Q3, Iovance Biotherapeutics's net income was $-91.25M. See Iovance Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 164.07M$ 1.19M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 40.08M$ -9.57M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 435.35M$ 450.99M$ 398.88M$ 342.70M$ 261.94M
Depreciation and Amortization
$ 43.61M$ 33.13M$ 21.14M$ 13.98M$ 1.14M
EBITDA
$ -351.67M$ -427.43M$ -377.74M$ -328.72M$ -260.80M
Operating Income
$ -395.28M$ -460.56M$ -398.88M$ -342.70M$ -261.94M
Other Income/Expenses
$ 20.27M$ 13.04M$ 2.98M$ 451.00K$ 2.36M
Pretax Income
$ -375.00M$ -447.52M$ -395.89M$ -342.25M$ -259.58M
Net Income
$ -372.18M$ -444.04M$ -395.89M$ -342.25M$ -259.58M
Per Share Metrics
Basic EPS
$ -1.28$ -1.89$ -2.49$ -2.23$ -1.88
Diluted EPS
$ -1.28$ -1.89$ -2.49$ -2.23$ -1.88
Weighted Average Shares Outstanding
289.88M 235.13M 159.26M 153.41M 138.30M
Weighted Average Shares Outstanding (Diluted)
289.88M 235.13M 159.26M 153.41M 138.30M
Currency in USD

Iovance Biotherapeutics Earnings and Revenue History